{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T12:55:06Z","timestamp":1780145706865,"version":"3.54.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s40264-025-01591-0","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T05:44:44Z","timestamp":1754372684000},"page":"9-25","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Impact of COVID-19 and COVID-19 Vaccination on Detection, Assessment, and Management of Suspected Acute Drug\u2010Induced Liver Injury Occurring during Clinical Trials: Consensus Recommendations from the IQ DILI Initiative"],"prefix":"10.1007","volume":"49","author":[{"given":"Melissa","family":"Palmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Seekins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Avigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Marcinak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don C.","family":"Rockey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie","family":"Regev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet K.","family":"Shastri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4033-4614","authenticated-orcid":false,"given":"Ajit","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"issue":"1","key":"1591_CR1","first-page":"157","volume":"91","author":"D Cucinotta","year":"2020","unstructured":"Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157\u201360.","journal-title":"Acta Biomed"},{"key":"1591_CR2","unstructured":"(FDA); USFaDA. Coronavirus (COVID-19) update: FDA issues guidance for conducting clinical trials. 2020."},{"key":"1591_CR3","unstructured":"U.S. Food and Drug Administration (FDA). Policy for coronavirus disease-2019 tests (Revised). https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/policy-coronavirus-disease-2019-tests-revised."},{"key":"1591_CR4","unstructured":"American Association for the Study of Liver Diseases (AASLD). Patient resources. 2023; Available from: https:\/\/www.aasld.org\/patient-resources"},{"issue":"1","key":"1591_CR5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/hep.31281","volume":"72","author":"OK Fix","year":"2020","unstructured":"Fix OK, Hameed B, Fontana RJ, Kwok RM, McGuire BM, Mulligan DC, et al. Clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pandemic: AASLD expert panel consensus statement. Hepatology. 2020;72(1):287\u2013304.","journal-title":"Hepatology"},{"key":"1591_CR6","unstructured":"Center for Disease Control and Prevention (CDC). End of the federal COVID-19 public health emergency (PHE) declaration. 2023; Available from: https:\/\/archive.cdc.gov\/#\/details?url=https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/your-health\/end-of-phe.html"},{"key":"1591_CR7","unstructured":"Centers for Disease Control and Prevention (CDC). United States COVID-19 deaths, emergency department (ED) visits, and test positivity by geographic area. 2024; Available from: https:\/\/covid.cdc.gov\/covid-data-tracker\/#maps_percent-covid-deaths"},{"key":"1591_CR8","unstructured":"IQ DIrug Induced Liver Injury Initiative (IQ DIILI). IQ DILI. Available from: https:\/\/www.iqdili.org\/"},{"issue":"3","key":"1591_CR9","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s00535-021-01760-9","volume":"56","author":"D Li","year":"2021","unstructured":"Li D, Ding X, Xie M, Tian D, Xia L. COVID-19-associated liver injury: from bedside to bench. J Gastroenterol. 2021;56(3):218\u201330.","journal-title":"J Gastroenterol"},{"issue":"2","key":"1591_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-80.e8.","journal-title":"Cell"},{"issue":"6518","key":"1591_CR11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1126\/science.abd3072","volume":"370","author":"JL Daly","year":"2020","unstructured":"Daly JL, Simonetti B, Klein K, Chen KE, Williamson MK, Ant\u00f3n-Pl\u00e1garo C, et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. 2020;370(6518):861\u20135.","journal-title":"Science"},{"issue":"2","key":"1591_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281-92.e6.","journal-title":"Cell"},{"issue":"6","key":"1591_CR13","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1053\/j.gastro.2020.02.055","volume":"158","author":"F Xiao","year":"2020","unstructured":"Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158(6):1831-3.e3.","journal-title":"Gastroenterology"},{"issue":"1","key":"1591_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbrc.2020.03.044","volume":"526","author":"F Qi","year":"2020","unstructured":"Qi F, Qian S, Zhang S, Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun. 2020;526(1):135\u201340.","journal-title":"Biochem Biophys Res Commun"},{"key":"1591_CR15","doi-asserted-by":"crossref","unstructured":"Seow JJW, Pai R, Mishra A, Shepherdson E, Lim TKH, Goh BKP, et al. Single-cell RNA-seq reveals angiotensin-converting enzyme 2 and transmembrane serine protease 2 expression in TROP2+ liver progenitor cells: implications in coronavirus disease 2019-associated liver dysfunction. Front Med. 2021; 2021-April-22;8.","DOI":"10.3389\/fmed.2021.603374"},{"issue":"4","key":"1591_CR16","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jhep.2020.05.002","volume":"73","author":"Y Wang","year":"2020","unstructured":"Wang Y, Liu S, Liu H, Li W, Lin F, Jiang L, et al. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J Hepatol. 2020;73(4):807\u201316.","journal-title":"J Hepatol"},{"issue":"5","key":"1591_CR17","doi-asserted-by":"publisher","first-page":"350","DOI":"10.7326\/M20-2566","volume":"173","author":"SF Lax","year":"2020","unstructured":"Lax SF, Skok K, Zechner P, Kessler HH, Kaufmann N, Koelblinger C, et al. Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series. Ann Intern Med. 2020;173(5):350\u201361.","journal-title":"Ann Intern Med"},{"issue":"6","key":"1591_CR18","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/ajcp\/aqab009","volume":"155","author":"Y Chornenkyy","year":"2021","unstructured":"Chornenkyy Y, Mejia-Bautista M, Brucal M, Blanke T, Dittmann D, Yeldandi A, et al. Liver pathology and SARS-CoV-2 detection in formalin-fixed tissue of patients with COVID-19. Am J Clin Pathol. 2021;155(6):802\u201314.","journal-title":"Am J Clin Pathol"},{"key":"1591_CR19","doi-asserted-by":"crossref","unstructured":"Kaltschmidt B, Fitzek A, Schaedler J, F\u00f6rster C, Kaltschmidt C, Hansen T, et al. Hepatic vasculopathy and regenerative responses of the liver in fatal cases of COVID-19. Clin Gastroenterol Hepatol. 2021 01\/29;19.","DOI":"10.1016\/j.cgh.2021.01.044"},{"issue":"4","key":"1591_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250708","volume":"16","author":"S Peiris","year":"2021","unstructured":"Peiris S, Mesa H, Aysola A, Manivel J, Toledo J, Borges-Sa M, et al. Pathological findings in organs and tissues of patients with COVID-19: a systematic review. PLoS ONE. 2021;16(4): e0250708.","journal-title":"PLoS ONE"},{"issue":"1","key":"1591_CR21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/gutjnl-2021-324280","volume":"71","author":"CCL Cheung","year":"2022","unstructured":"Cheung CCL, Goh D, Lim X, Tien TZ, Lim JCT, Lee JN, et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut. 2022;71(1):226\u20139.","journal-title":"Gut"},{"issue":"7865","key":"1591_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41586-021-03570-8","volume":"595","author":"TM Delorey","year":"2021","unstructured":"Delorey TM, Ziegler CGK, Heimberg G, Normand R, Yang Y, Segerstolpe \u00c5, et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature. 2021;595(7865):107\u201313.","journal-title":"Nature"},{"issue":"5","key":"1591_CR23","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1172\/JCI137647","volume":"130","author":"SF Pedersen","year":"2020","unstructured":"Pedersen SF, Ho YC. SARS-CoV-2: a storm is raging. J Clin Invest. 2020;130(5):2202\u20135.","journal-title":"J Clin Invest"},{"issue":"2","key":"1591_CR24","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.dld.2020.08.004","volume":"53","author":"M Effenberger","year":"2021","unstructured":"Effenberger M, Grander C, Grabherr F, Griesmacher A, Ploner T, Hartig F, et al. Systemic inflammation as fuel for acute liver injury in COVID-19. Dig Liver Dis. 2021;53(2):158\u201365.","journal-title":"Dig Liver Dis"},{"issue":"3","key":"1591_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100258","volume":"3","author":"N Shafran","year":"2021","unstructured":"Shafran N, Issachar A, Shochat T, Shafran IH, Bursztyn M, Shlomai A. Abnormal liver tests in patients with SARS-CoV-2 or influenza\u2014prognostic similarities and temporal disparities. JHEP Rep. 2021;3(3): 100258.","journal-title":"JHEP Rep."},{"issue":"10223","key":"1591_CR26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.","journal-title":"Lancet"},{"issue":"5","key":"1591_CR27","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","volume":"5","author":"C Zhang","year":"2020","unstructured":"Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5(5):428\u201330.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"1591_CR28","doi-asserted-by":"crossref","unstructured":"Palmer M, Seekins D, Dash A, Marcinak J, Regev A, Lewis JH. The impact of COVID-19 and Covid-19 vaccination on detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials: consensus recommendations from the IQ DILI Consortium. AASLD The Liver Meeting; 2024; San Diego, CA; 2024. p. 1404.","DOI":"10.1007\/s40264-025-01591-0"},{"issue":"19","key":"1591_CR29","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.3748\/wjg.v26.i19.2286","volume":"26","author":"J Wu","year":"2020","unstructured":"Wu J, Song S, Cao HC, Li LJ. Liver diseases in COVID-19: etiology, treatment and prognosis. World J Gastroenterol. 2020;26(19):2286\u201393.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"1591_CR30","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/liv.14435","volume":"40","author":"L Xu","year":"2020","unstructured":"Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020;40(5):998\u20131004.","journal-title":"Liver Int"},{"issue":"2","key":"1591_CR31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/apt.15813","volume":"52","author":"I Garrido","year":"2020","unstructured":"Garrido I, Liberal R, Macedo G. Review article: COVID-19 and liver disease-what we know on 1st May 2020. Aliment Pharmacol Ther. 2020;52(2):267\u201375.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"1591_CR32","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/gutjnl-2020-322072","volume":"70","author":"DK Yadav","year":"2021","unstructured":"Yadav DK, Singh A, Zhang Q, Bai X, Zhang W, Yadav RK, et al. Involvement of liver in COVID-19: systematic review and meta-analysis. Gut. 2021;70(4):807\u20139.","journal-title":"Gut"},{"issue":"5","key":"1591_CR33","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.jhep.2020.06.006","volume":"73","author":"D Jothimani","year":"2020","unstructured":"Jothimani D, Venugopal R, Abedin MF, Kaliamoorthy I, Rela M. COVID-19 and the liver. J Hepatol. 2020;73(5):1231\u201340.","journal-title":"J Hepatol"},{"issue":"4","key":"1591_CR34","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jhep.2020.06.028","volume":"73","author":"Y Wang","year":"2020","unstructured":"Wang Y, Lu F, Zhao J. Reply to: correspondence relating to \u201cSARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.\u201d J Hepatol. 2020;73(4):996\u20138.","journal-title":"J Hepatol"},{"issue":"5","key":"1591_CR35","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S1473-3099(20)30144-4","volume":"20","author":"AJ Kucharski","year":"2020","unstructured":"Kucharski AJ, Russell TW, Diamond C, Liu Y, Edmunds J, Funk S, et al. Early dynamics of transmission and control of COVID-19: a mathematical modelling study. Lancet Infect Dis. 2020;20(5):553\u20138.","journal-title":"Lancet Infect Dis"},{"issue":"10223","key":"1591_CR36","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507\u201313.","journal-title":"Lancet"},{"issue":"11","key":"1591_CR37","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1038\/s41379-020-00649-x","volume":"33","author":"SM Lagana","year":"2020","unstructured":"Lagana SM, Kudose S, Iuga AC, Lee MJ, Fazlollahi L, Remotti HE, et al. Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data. Mod Pathol. 2020;33(11):2147\u201355.","journal-title":"Mod Pathol"},{"issue":"1","key":"1591_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/01.NPR.0000722316.63824.f9","volume":"46","author":"R Clark","year":"2021","unstructured":"Clark R, Waters B, Stanfill AG. Elevated liver function tests in COVID-19: causes, clinical evidence, and potential treatments. Nurse Pract. 2021;46(1):21\u20136.","journal-title":"Nurse Pract"},{"key":"1591_CR39","doi-asserted-by":"crossref","unstructured":"de Lima IC, de Menezes DC, Uesugi JHE, Bichara CNC, da Costa Vasconcelos PF, Quaresma JAS, et al. Liver function in patients with long-term coronavirus disease 2019 of up to 20 months: a cross-sectional study. Int J Environ Res Public Health. 2023;20(7):5281.","DOI":"10.3390\/ijerph20075281"},{"issue":"22","key":"1591_CR40","volume":"17","author":"A Osorio Mart\u00ednez","year":"2021","unstructured":"Osorio Mart\u00ednez A, Gonz\u00e1lez-Razo VT, Navarro-S\u00e1nchez V, Souto Meiri\u00f1o CA, Ahumada-Ayala M. SARS-CoV-2-related subacute thyroiditis, myocarditis, and hepatitis after full resolution of COVID-19 serum markers. Am J Case Rep. 2021;17(22): e932321.","journal-title":"Am J Case Rep."},{"issue":"6","key":"1591_CR41","doi-asserted-by":"publisher","first-page":"941","DOI":"10.14309\/ajg.0000000000000660","volume":"115","author":"P Wander","year":"2020","unstructured":"Wander P, Epstein M, Bernstein D. COVID-19 presenting as acute hepatitis. Am J Gastroenterol. 2020;115(6):941\u20132.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1591_CR42","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1016\/j.jinf.2020.09.001","volume":"82","author":"M Bongiovanni","year":"2021","unstructured":"Bongiovanni M, Zago T. Acute hepatitis caused by asymptomatic COVID-19 infection. J Infect. 2021;82(1):e25\u20136.","journal-title":"J Infect"},{"issue":"7","key":"1591_CR43","first-page":"S125","volume":"31","author":"A Khan","year":"2021","unstructured":"Khan A, Qayum I, Khan AW, Hanif M, Naeem A. Acute hepatitis as a rare presentation of COVID-19. J Coll Physicians Surg Pak. 2021;31(7):S125\u20136.","journal-title":"J Coll Physicians Surg Pak"},{"issue":"5","key":"1591_CR44","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nrgastro.2009.46","volume":"6","author":"P Ruemmele","year":"2009","unstructured":"Ruemmele P, Hofstaedter F, Gelbmann CM. Secondary sclerosing cholangitis. Nat Rev Gastroenterol Hepatol. 2009;6(5):287\u201395.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"1591_CR45","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1159\/000528689","volume":"104","author":"M Seifert","year":"2023","unstructured":"Seifert M, Kneiseler G, Dechene A. Secondary sclerosing cholangitis due to severe COVID-19: an emerging disease entity? Digestion. 2023;104(4):306\u201312.","journal-title":"Digestion"},{"issue":"10","key":"1591_CR46","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.5858\/arpa.2021-0605-SA","volume":"146","author":"AR Shih","year":"2022","unstructured":"Shih AR, Hatipoglu D, Wilechansky R, Goiffon R, Deshpande V, Misdraji J, et al. Persistent cholestatic injury and secondary sclerosing cholangitis in COVID-19 patients. Arch Pathol Lab Med. 2022;146(10):1184\u201393.","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"1591_CR47","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/j.1572-0241.2007.01118.x","volume":"102","author":"CM Gelbmann","year":"2007","unstructured":"Gelbmann CM, R\u00fcmmele P, Wimmer M, Hofst\u00e4dter F, G\u00f6hlmann B, Endlicher E, et al. Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Am J Gastroenterol. 2007;102(6):1221\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1591_CR48","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13054-022-04019-8","volume":"26","author":"PD Wendel-Garcia","year":"2022","unstructured":"Wendel-Garcia PD, Erlebach R, Hofmaenner DA, Camen G, Schuepbach RA, J\u00fcngst C, et al. Long-term ketamine infusion-induced cholestatic liver injury in COVID-19-associated acute respiratory distress syndrome. Crit Care. 2022;26(1):148 (2022\/05\/23).","journal-title":"Crit Care"},{"key":"1591_CR49","doi-asserted-by":"crossref","unstructured":"Lee A, Wein AN, Doyle MBM, Chapman WC. Liver transplantation for post-COVID-19 sclerosing cholangitis. BMJ Case Rep. 2021;14(8).","DOI":"10.1136\/bcr-2021-244168"},{"issue":"1","key":"1591_CR50","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12871-023-02006-2","volume":"23","author":"J Henrie","year":"2023","unstructured":"Henrie J, Gerard L, Declerfayt C, Lejeune A, Baldin P, Robert A, et al. Profile of liver cholestatic biomarkers following prolonged ketamine administration in patients with COVID-19. BMC Anesthesiol. 2023;23(1):44 (2023\/02\/07).","journal-title":"BMC Anesthesiol"},{"issue":"5","key":"1591_CR51","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.14309\/ajg.0000000000001154","volume":"116","author":"NC Roth","year":"2021","unstructured":"Roth NC, Kim A, Vitkovski T, Xia J, Ramirez G, Bernstein D, et al. Post-COVID-19 cholangiopathy: a novel entity. Am J Gastroenterol. 2021;116(5):1077\u201382.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"1591_CR52","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/hep.32582","volume":"76","author":"L Hartl","year":"2022","unstructured":"Hartl L, Haslinger K, Angerer M, Semmler G, Schneeweiss-Gleixner M, Jachs M, et al. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease. Hepatology. 2022;76(6):1563\u201375.","journal-title":"Hepatology"},{"issue":"8","key":"1591_CR53","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1016\/j.asjsur.2022.11.002","volume":"46","author":"HA El-Hady","year":"2023","unstructured":"El-Hady HA, Mahmoud Abd-Elwahab ES, Mostafa-Hedeab G, Shawky EM. Portal vein thrombosis in patients with COVID-19: a systematic review. Asian J Surg. 2023;46(8):3017\u201326.","journal-title":"Asian J Surg"},{"key":"1591_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.794599","volume":"8","author":"S Kheyrandish","year":"2021","unstructured":"Kheyrandish S, Rastgar A, Arab-Zozani M, Sarab GA. Portal vein thrombosis might develop by COVID-19 infection or vaccination: a systematic review of case-report studies. Front Med (Lausanne). 2021;8: 794599.","journal-title":"Front Med (Lausanne)."},{"issue":"7","key":"1591_CR55","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/imj.15420","volume":"51","author":"JK Hong","year":"2021","unstructured":"Hong JK, Chopra S, Kahn JA, Kim B, Khemichian S. Autoimmune hepatitis triggered by COVID-19. Intern Med J. 2021;51(7):1182\u20133.","journal-title":"Intern Med J"},{"issue":"10","key":"1591_CR56","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1111\/liv.15044","volume":"41","author":"G Kaba\u00e7am","year":"2021","unstructured":"Kaba\u00e7am G, Wahlin S, Efe C. Autoimmune hepatitis triggered by COVID-19: a report of two cases. Liver Int. 2021;41(10):2527\u20138.","journal-title":"Liver Int"},{"issue":"1","key":"1591_CR57","first-page":"8409269","volume":"2022","author":"FA Durazo","year":"2022","unstructured":"Durazo FA, Kristbaum K, Miller J, Saeian K, Selim M, Hong JC. De novo autoimmune hepatitis after COVID-19 infection in an unvaccinated patient. Case Rep Hepatol. 2022;2022(1):8409269.","journal-title":"Case Rep Hepatol."},{"issue":"11","key":"1591_CR58","first-page":"528","volume":"73","author":"G Rajendiran","year":"2020","unstructured":"Rajendiran G, Cowman B, Erickson K, Oliver T, Manatsathit W. Autoimmune hepatitis associated with COVID-19 infection\u2014a diagnostic and therapeutic dilemma. S D Med. 2020;73(11):528\u201332.","journal-title":"S D Med."},{"issue":"9","key":"1591_CR59","first-page":"e45688","volume":"15","author":"HE Lee","year":"2023","unstructured":"Lee HE, Zhang J, Wilhelm AB, Stevenson HL, Merwat S. Seronegative autoimmune hepatitis: a rare manifestation of COVID-19. Cureus. 2023;15(9):e45688.","journal-title":"Cureus"},{"issue":"5","key":"1591_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102524","volume":"19","author":"F Caso","year":"2020","unstructured":"Caso F, Costa L, Ruscitti P, Navarini L, Del Puente A, Giacomelli R, et al. Could Sars-coronavirus-2 trigger autoimmune and\/or autoinflammatory mechanisms in genetically predisposed subjects? Autoimmun Rev. 2020;19(5): 102524.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"1591_CR61","volume":"14","author":"J Khawaja","year":"2022","unstructured":"Khawaja J, Bawa A, Omer H, Ashraf F, Zulfiqar P. COVID-19 infection presenting as an isolated severe acute liver failure. Cureus. 2022;14(5): e24873.","journal-title":"Cureus"},{"issue":"43","key":"1591_CR62","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022818","volume":"99","author":"S Melquist","year":"2020","unstructured":"Melquist S, Estepp K, Aleksandrovich Y, Lee A, Beiseker A, Hamedani FS, et al. COVID-19 presenting as fulminant hepatic failure: a case report. Medicine (Baltimore). 2020;99(43): e22818.","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"1591_CR63","volume":"12","author":"D Gurala","year":"2020","unstructured":"Gurala D, Al Moussawi H, Philipose J, Abergel JR. Acute liver failure in a COVID-19 patient without any preexisting liver disease. Cureus. 2020;12(8): e10045.","journal-title":"Cureus."},{"issue":"7","key":"1591_CR64","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1136\/gutjnl-2020-321350","volume":"69","author":"S Weber","year":"2020","unstructured":"Weber S, Mayerle J, Irlbeck M, Gerbes AL. Severe liver failure during SARS-CoV-2 infection. Gut. 2020;69(7):1365\u20137.","journal-title":"Gut"},{"issue":"10","key":"1591_CR65","volume":"16","author":"I Tanaka","year":"2024","unstructured":"Tanaka I, Sato Y, Sano C, Ohta R. Pancytopenia and acute liver failure caused by mild COVID-19 in an older patient: a case report. Cureus. 2024;16(10): e72681.","journal-title":"Cureus"},{"key":"1591_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.08.932","author":"S Sarkar","year":"2020","unstructured":"Sarkar S, Rapista N, Jean L-G. Corona virus disease-19-induced acute liver failure leading to severe metabolic acidosis. Chest. 2020. https:\/\/doi.org\/10.1016\/j.chest.2020.08.932.","journal-title":"Chest"},{"issue":"10","key":"1591_CR67","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.3390\/v16101646","volume":"16","author":"VC-W Chen","year":"2024","unstructured":"Chen VC-W, Joseph CR, Chan WOY, Sia WR, Su Q, Sam XX, et al. Inflammasome-driven fatal acute-on-chronic liver failure triggered by mild COVID-19. Viruses. 2024;16(10):1646.","journal-title":"Viruses"},{"issue":"Suppl 1","key":"1591_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/liv.14854","volume":"41","author":"T Herta","year":"2021","unstructured":"Herta T, Berg T. COVID-19 and the liver\u2014lessons learned. Liver Int. 2021;41(Suppl 1):1\u20138.","journal-title":"Liver Int"},{"issue":"42","key":"1591_CR69","doi-asserted-by":"publisher","first-page":"7350","DOI":"10.3748\/wjg.v27.i42.7350","volume":"27","author":"D Bernstein","year":"2021","unstructured":"Bernstein D, Roth N, Kim A, Epstein M, Hirschwerk D, Kvasnovsky CL, et al. Presentation, patterns and predictive value of baseline liver tests on outcomes in COVID-19 patients without chronic liver disease. World J Gastroenterol. 2021;27(42):7350\u201361.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1591_CR70","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/hep.31301","volume":"72","author":"F Lei","year":"2020","unstructured":"Lei F, Liu YM, Zhou F, Qin JJ, Zhang P, Zhu L, et al. Longitudinal association between markers of liver injury and mortality in COVID-19 in China. Hepatology. 2020;72(2):389\u201398.","journal-title":"Hepatology"},{"key":"1591_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2020.100298","volume":"21","author":"M Mendizabal","year":"2021","unstructured":"Mendizabal M, Pi\u00f1ero F, Ridruejo E, Anders M, Silveyra MD, Torre A, et al. Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission. Ann Hepatol. 2021;21: 100298.","journal-title":"Ann Hepatol"},{"issue":"3","key":"1591_CR72","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.rgmxen.2020.05.002","volume":"85","author":"JA Velarde-Ruiz Velasco","year":"2020","unstructured":"Velarde-Ruiz Velasco JA, Garc\u00eda-Jim\u00e9nez ES, Remes-Troche JM. Hepatic manifestations and impact of COVID-19 on the cirrhotic patient. Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition). 2020;85(3):303\u201311.","journal-title":"Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"},{"issue":"3","key":"1591_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2020.100113","volume":"2","author":"T Boettler","year":"2020","unstructured":"Boettler T, Newsome PN, Mondelli MU, Maticic M, Cordero E, Cornberg M, et al. Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. JHEP Rep. 2020;2(3): 100113.","journal-title":"JHEP Rep."},{"issue":"2","key":"1591_CR74","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jhep.2020.03.044","volume":"73","author":"D Ji","year":"2020","unstructured":"Ji D, Qin E, Xu J, Zhang D, Cheng G, Wang Y, et al. Non-alcoholic fatty liver diseases in patients with COVID-19: a retrospective study. J Hepatol. 2020;73(2):451\u20133.","journal-title":"J Hepatol"},{"issue":"1","key":"1591_CR75","doi-asserted-by":"publisher","DOI":"10.1097\/01.HC9.0000897224.68874.de","volume":"7","author":"ES Aby","year":"2023","unstructured":"Aby ES, Moafa G, Latt N, Sultan MT, Cacioppo PA, Kumar S, et al. Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study. Hepatol Comm. 2023;7(1): e8874.","journal-title":"Hepatol Comm"},{"issue":"3","key":"1591_CR76","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5409\/wjcp.v12.i3.57","volume":"12","author":"R Bitar","year":"2023","unstructured":"Bitar R, Elghoudi AA, Rawat D, Azaz A, Miqdady M, Narchi H. COVID-19-induced liver injury in infants, children, and adolescents. World J Clin Pediatr. 2023;12(3):57\u201367.","journal-title":"World J Clin Pediatr"},{"issue":"18","key":"1591_CR77","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708\u201320.","journal-title":"N Engl J Med"},{"issue":"2","key":"1591_CR78","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1056\/NEJMc2007617","volume":"383","author":"N Parri","year":"2020","unstructured":"Parri N, Lenge M, Buonsenso D. Children with Covid-19 in pediatric emergency departments in Italy. N Engl J Med. 2020;383(2):187\u201390.","journal-title":"N Engl J Med"},{"issue":"Suppl 26","key":"1591_CR79","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/pai.13373","volume":"31","author":"E Chiappini","year":"2020","unstructured":"Chiappini E, Licari A, Motisi MA, Manti S, Marseglia GL, Galli L, et al. Gastrointestinal involvement in children with SARS-COV-2 infection: an overview for the pediatrician. Pediatr Allergy Immunol. 2020;31(Suppl 26):92\u20135.","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"1591_CR80","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/MPG.0000000000003521","volume":"75","author":"S Cooper","year":"2022","unstructured":"Cooper S, Tobar A, Konen O, Orenstein N, Kropach Gilad N, Landau YE, et al. Long COVID-19 liver manifestation in children. J Pediatr Gastroenterol Nutr. 2022;75(3):244\u201351.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10350","key":"1591_CR81","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S0140-6736(22)01214-4","volume":"400","author":"AV Ballering","year":"2022","unstructured":"Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400(10350):452\u201361.","journal-title":"Lancet"},{"issue":"1","key":"1591_CR82","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41467-023-36223-7","volume":"14","author":"E Xu","year":"2023","unstructured":"Xu E, Xie Y, Al-Aly Z. Long-term gastrointestinal outcomes of COVID-19. Nat Comm. 2023;14(1):983 (2023\/03\/07).","journal-title":"Nat Comm"},{"issue":"1","key":"1591_CR83","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12916-023-03236-4","volume":"22","author":"Y Ma","year":"2024","unstructured":"Ma Y, Zhang L, Wei R, Dai W, Zeng R, Luo D, et al. Risks of digestive diseases in long COVID: evidence from a population-based cohort study. BMC Med. 2024;22(1):14 (2024\/01\/10).","journal-title":"BMC Med"},{"key":"1591_CR84","unstructured":"U.S. Food and Drug Administration (FDA). PAXLOVID\u2122 (nirmatrelvir tablets; ritonavir tablets), co-packaged for oral use Initial U.S. Approval: 2023. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/217188s000lbl.pdf."},{"issue":"19","key":"1591_CR85","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1056\/NEJMoa2015301","volume":"383","author":"JD Goldman","year":"2020","unstructured":"Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Montejano R, et al. Remdesivir for 5 or 10 days in patients with severe Covid-19. N Engl J Med. 2020;383(19):1827\u201337.","journal-title":"N Engl J Med"},{"issue":"10","key":"1591_CR86","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000000866","volume":"9","author":"K Lin","year":"2022","unstructured":"Lin K, Gausman V, Poles M, Popov V. Acute liver failure secondary to remdesivir in the treatment of COVID-19. ACG Case Rep J. 2022;9(10): e00866.","journal-title":"ACG Case Rep J."},{"key":"1591_CR87","unstructured":"J. K. Coronavirus | In rush for \u2018immunity\u2019, Ayurveda supplements have an untested run. Hindu. 2020."},{"issue":"22","key":"1591_CR88","doi-asserted-by":"publisher","first-page":"5142","DOI":"10.1002\/cncr.26164","volume":"117","author":"A Naing","year":"2011","unstructured":"Naing A, Stephen SK, Frenkel M, Chandhasin C, Hong DS, Lei X, et al. Prevalence of complementary medicine use in a phase 1 clinical trials program: the MD Anderson Cancer Center Experience. Cancer. 2011;117(22):5142\u201350.","journal-title":"Cancer"},{"key":"1591_CR89","doi-asserted-by":"crossref","unstructured":"\u00d6nlen Y, Savas L, Ozer B, Iris N. Brief report\u2014the elevation of liver enzymes due to hepatitis B vaccine. Eur J Gen Med (ISSN: 1304-3897) Vol 3 Num 4. 2006 10\/01;3.","DOI":"10.29333\/ejgm\/82411"},{"issue":"30","key":"1591_CR90","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011621","volume":"97","author":"T Sasaki","year":"2018","unstructured":"Sasaki T, Suzuki Y, Ishida K, Kakisaka K, Abe H, Sugai T, et al. Autoimmune hepatitis following influenza virus vaccination: two case reports. Medicine (Baltimore). 2018;97(30): e11621.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1591_CR91","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/00365521.2016.1224379","volume":"52","author":"MA van Gemeren","year":"2017","unstructured":"van Gemeren MA, van Wijngaarden P, Doukas M, de Man RA. Vaccine-related autoimmune hepatitis: the same disease as idiopathic autoimmune hepatitis? Two clinical reports and review. Scand J Gastroenterol. 2017;52(1):18\u201322.","journal-title":"Scand J Gastroenterol"},{"issue":"15","key":"1591_CR92","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.3748\/wjg.v13.i15.2238","volume":"13","author":"PA Berry","year":"2007","unstructured":"Berry PA, Smith-Laing G. Hepatitis A vaccine associated with autoimmune hepatitis. World J Gastroenterol. 2007;13(15):2238\u20139.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"1591_CR93","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2022-003485","volume":"30","author":"M Mathew","year":"2023","unstructured":"Mathew M, John SB, Sebastian J, Ravi MD. COVID-19 vaccine triggered autoimmune hepatitis: case report. Eur J Hosp Pharm. 2023;30(5): e27.","journal-title":"Eur J Hosp Pharm"},{"issue":"1","key":"1591_CR94","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s10620-005-1303-z","volume":"50","author":"GR Veerappan","year":"2005","unstructured":"Veerappan GR, Mulhall BP, Holtzmuller KC. Vaccination-induced autoimmune hepatitis. Dig Dis Sci. 2005;50(1):212\u20133.","journal-title":"Dig Dis Sci"},{"issue":"26","key":"1591_CR95","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.3748\/wjg.v11.i26.4114","volume":"11","author":"A Csepregi","year":"2005","unstructured":"Csepregi A, Treiber G, R\u00f6cken C, Malfertheiner P. Acute exacerbation of autoimmune hepatitis induced by Twinrix. World J Gastroenterol. 2005;11(26):4114\u20136.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"1591_CR96","first-page":"2280","volume":"5","author":"RY Rajegowda","year":"2017","unstructured":"Rajegowda RY, Nanjappa NB, Muthahanumai NK. Anti-rabies vaccination induced hepatotoxicity\u2014a case report. Int J Basic Clin Pharmacol. 2017;5(5):2280\u20132.","journal-title":"Int J Basic Clin Pharmacol."},{"issue":"6","key":"1591_CR97","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/cmi.2017.151","volume":"15","author":"Y Segal","year":"2018","unstructured":"Segal Y, Shoenfeld Y. Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction. Cell Mol Immunol. 2018;15(6):586\u201394.","journal-title":"Cell Mol Immunol"},{"issue":"27","key":"1591_CR98","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603\u201315.","journal-title":"N Engl J Med"},{"issue":"6","key":"1591_CR99","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1002\/hep.32572","volume":"76","author":"C Efe","year":"2022","unstructured":"Efe C, Kulkarni AV, Terziroli Beretta-Piccoli B, Magro B, St\u00e4ttermayer A, Cengiz M, et al. Liver injury after SARS-CoV-2 vaccination: features of immune-mediated hepatitis, role of corticosteroid therapy and outcome. Hepatology. 2022;76(6):1576\u201386.","journal-title":"Hepatology"},{"issue":"9","key":"1591_CR100","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1002\/hep4.1979","volume":"6","author":"A Roy","year":"2022","unstructured":"Roy A, Verma N, Singh S, Pradhan P, Taneja S, Singh M. Immune-mediated liver injury following COVID-19 vaccination: a systematic review. Hepatol Commun. 2022;6(9):2513\u201322.","journal-title":"Hepatol Commun"},{"issue":"1","key":"1591_CR101","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jhep.2021.04.003","volume":"75","author":"F Bril","year":"2021","unstructured":"Bril F, Al Diffalha S, Dean M, Fettig DM. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty? J Hepatol. 2021;75(1):222\u20134.","journal-title":"J Hepatol"},{"issue":"5","key":"1591_CR102","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jhep.2021.06.014","volume":"75","author":"D Clayton-Chubb","year":"2021","unstructured":"Clayton-Chubb D, Schneider D, Freeman E, Kemp W, Roberts SK. Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine. J Hepatol. 2021;75(5):1249\u201350.","journal-title":"J Hepatol"},{"issue":"5","key":"1591_CR103","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.jhep.2021.07.005","volume":"75","author":"F Lodato","year":"2021","unstructured":"Lodato F, Larocca A, D\u2019Errico A, Cennamo V. An unusual case of acute cholestatic hepatitis after m-RNABNT162b2 (Comirnaty) SARS-CoV-2 vaccine: coincidence, autoimmunity or drug-related liver injury. J Hepatol. 2021;75(5):1254\u20136.","journal-title":"J Hepatol"},{"issue":"5","key":"1591_CR104","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.jhep.2021.06.004","volume":"75","author":"MC Londo\u00f1o","year":"2021","unstructured":"Londo\u00f1o MC, Gratac\u00f3s-Gin\u00e8s J, S\u00e1ez-Pe\u00f1ataro J. Another case of autoimmune hepatitis after SARS-CoV-2 vaccination - still casualty? J Hepatol. 2021;75(5):1248\u20139.","journal-title":"J Hepatol"},{"issue":"3","key":"1591_CR105","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jhep.2021.05.038","volume":"75","author":"A Rocco","year":"2021","unstructured":"Rocco A, Sgamato C, Compare D, Nardone G. Autoimmune hepatitis following SARS-CoV-2 vaccine: may not be a casuality. J Hepatol. 2021;75(3):728\u20139.","journal-title":"J Hepatol"},{"key":"1591_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102710","volume":"123","author":"\u00c9 Vuille-Lessard","year":"2021","unstructured":"Vuille-Lessard \u00c9, Montani M, Bosch J, Semmo N. Autoimmune hepatitis triggered by SARS-CoV-2 vaccination. J Autoimmun. 2021;123: 102710.","journal-title":"J Autoimmun"},{"issue":"5","key":"1591_CR107","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.jhep.2021.06.044","volume":"75","author":"C McShane","year":"2021","unstructured":"McShane C, Kiat C, Rigby J, Crosbie \u00d3. The mRNA COVID-19 vaccine - a rare trigger of autoimmune hepatitis? J Hepatol. 2021;75(5):1252\u20134.","journal-title":"J Hepatol"},{"key":"1591_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102706","volume":"123","author":"M Ghielmetti","year":"2021","unstructured":"Ghielmetti M, Schaufelberger HD, Mieli-Vergani G, Cerny A, Dayer E, Vergani D, et al. Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: a novel clinical entity? J Autoimmun. 2021;123: 102706.","journal-title":"J Autoimmun"},{"issue":"5","key":"1591_CR109","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jhep.2021.06.009","volume":"75","author":"CK Tan","year":"2021","unstructured":"Tan CK, Wong YJ, Wang LM, Ang TL, Kumar R. Autoimmune hepatitis following COVID-19 vaccination: true causality or mere association? J Hepatol. 2021;75(5):1250\u20132.","journal-title":"J Hepatol"},{"issue":"1","key":"1591_CR110","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jhep.2021.08.006","volume":"76","author":"T Zhou","year":"2022","unstructured":"Zhou T, Fronhoffs F, Dold L, Strassburg CP, Weism\u00fcller TJ. New-onset autoimmune hepatitis following mRNA COVID-19 vaccination in a 36-year-old woman with primary sclerosing cholangitis - should we be more vigilant? J Hepatol. 2022;76(1):218\u201320.","journal-title":"J Hepatol"},{"issue":"3","key":"1591_CR111","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jhep.2021.09.031","volume":"76","author":"GS Zin Tun","year":"2022","unstructured":"Zin Tun GS, Gleeson D, Al-Joudeh A, Dube A. Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed. J Hepatol. 2022;76(3):747\u20139.","journal-title":"J Hepatol"},{"key":"1591_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102688","volume":"123","author":"M Rela","year":"2021","unstructured":"Rela M, Jothimani D, Vij M, Rajakumar A, Rammohan A. Auto-immune hepatitis following COVID vaccination. J Autoimmun. 2021;123: 102688.","journal-title":"J Autoimmun"},{"issue":"1","key":"1591_CR113","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jhep.2021.07.024","volume":"76","author":"H Shroff","year":"2022","unstructured":"Shroff H, Satapathy SK, Crawford JM, Todd NJ, VanWagner LB. Liver injury following SARS-CoV-2 vaccination: a multicenter case series. J Hepatol. 2022;76(1):211\u20134.","journal-title":"J Hepatol"},{"issue":"8","key":"1591_CR114","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.14309\/ajg.0000000000002702","volume":"119","author":"RJ Fontana","year":"2024","unstructured":"Fontana RJ, Li YJ, Vuppalanchi R, Kleiner DE, Gu J, Shroff H, et al. ERAP-1 and ERAP-2 variants in liver injury after COVID-19 mRNA vaccination: a US multicenter study. Am J Gastroenterol. 2024;119(8):1496\u2013505.","journal-title":"Am J Gastroenterol"},{"key":"1591_CR115","first-page":"S1449","volume":"76","author":"ML Shiffman","year":"2022","unstructured":"Shiffman ML. Drug induced liver injury (DILI) following vaccination against COVID-2. Hepatology. 2022;76:S1449\u201350.","journal-title":"Hepatology"},{"issue":"1","key":"1591_CR116","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jhep.2022.02.014","volume":"77","author":"J Guardiola","year":"2022","unstructured":"Guardiola J, Lammert C, Teal E, Chalasani N. Unexplained liver test elevations after SARS-CoV-2 vaccination. J Hepatol. 2022;77(1):251\u20133.","journal-title":"J Hepatol"},{"issue":"7","key":"1591_CR117","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","volume":"148","author":"N Chalasani","year":"2015","unstructured":"Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015;148(7):1340-52.e7.","journal-title":"Gastroenterology"},{"issue":"13","key":"1591_CR118","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1016\/j.cgh.2018.12.013","volume":"17","author":"C Lammert","year":"2019","unstructured":"Lammert C, Imler T, Teal E, Chalasani N. Patients with chronic liver disease suggestive of nonalcoholic fatty liver disease may be at higher risk for drug-induced liver injury. Clin Gastroenterol Hepatol. 2019;17(13):2814\u20135.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"1591_CR119","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/clpt.2011.58","volume":"89","author":"GP Aithal","year":"2011","unstructured":"Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011;89(6):806\u201315.","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"1591_CR120","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.jhep.2022.06.032","volume":"77","author":"CKH Wong","year":"2022","unstructured":"Wong CKH, Mak LY, Au ICH, Lai FTT, Li X, Wan EYF, et al. Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines. J Hepatol. 2022;77(5):1339\u201348.","journal-title":"J Hepatol"},{"issue":"3","key":"1591_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2024.101489","volume":"29","author":"A Barreira-D\u00edaz","year":"2024","unstructured":"Barreira-D\u00edaz A, Riveiro-Barciela M, Fern\u00e1ndez-Bonilla EM, Bernal V, Castiella A, Casado-Mart\u00edn M, et al. Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: a nationwide study. Ann Hepatol. 2024;29(3): 101489.","journal-title":"Ann Hepatol"},{"key":"1591_CR122","doi-asserted-by":"publisher","first-page":"365","DOI":"10.15585\/mmwr.mm7316a2","volume":"73","author":"S Smith-Jeffcoat","year":"2024","unstructured":"Smith-Jeffcoat S, Mellis A, Grijalva C, Talbot H, Schmitz J, Lutrick K, et al. SARS-CoV-2 viral shedding and rapid antigen test performance \u2014 respiratory virus transmission network, November 2022\u2013May 2023. MMWR Morb Mortal Wkly Rep. 2024;73:365\u201371.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1591_CR123","unstructured":"Centers for Disease Control and Prevention (CDC). Overview of Testing for SARS-CoV-2, the virus that causes COVID-19. 2023; Available from: https:\/\/archive.cdc.gov\/#\/details?url=https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/testing-overview.html"},{"key":"1591_CR124","unstructured":"Centers for Disease Control and Prevention (CDC). Ending isolation and precautions for people with COVID-19: interim guidance. 2022; Available from: https:\/\/archive.cdc.gov\/www_cdc_gov\/coronavirus\/2019-ncov\/hcp\/duration-isolation.html"},{"issue":"1","key":"1591_CR125","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12879-021-05950-x","volume":"21","author":"M Alene","year":"2021","unstructured":"Alene M, Yismaw L, Assemie MA, Ketema DB, Gietaneh W, Birhan TY. Serial interval and incubation period of COVID-19: a systematic review and meta-analysis. BMC Infect Dis. 2021;21(1):257 (2021\/03\/11).","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1591_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14740338.2023.2172158","volume":"22","author":"F Ceban","year":"2023","unstructured":"Ceban F, Subramaniapillai M, Rosenblat JD, Mansur RB, McIntyre RS. Can COVID-19 have a clinically significant effect on drug metabolism? Expert Opin Drug Saf. 2023;22(1):1\u20133.","journal-title":"Expert Opin Drug Saf"},{"key":"1591_CR127","unstructured":"Council for International Organizations of Medical Sciences (CIOMS). Drug-induced liver injury (DILI): current status and future directions for drug development and the post-market setting. https:\/\/cioms.ch\/wp-content\/uploads\/2020\/06\/CIOMS_DILI_Web_16Jun2020.pdf."},{"issue":"2","key":"1591_CR128","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s40264-020-01014-2","volume":"44","author":"WR Treem","year":"2021","unstructured":"Treem WR, Palmer M, Lonjon-Domanec I, Seekins D, Dimick-Santos L, Avigan MI, et al. Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in adults with chronic viral hepatitis and adults with cirrhosis secondary to hepatitis B, C and nonalcoholic steatohepatitis. Drug Saf. 2021;44(2):133\u201365.","journal-title":"Drug Saf"},{"key":"1591_CR129","unstructured":"Puckey M. Paxlovid: uses, dosage, side effects, warnings. 2024; Available from: https:\/\/www.drugs.com\/paxlovid.html"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-025-01591-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-025-01591-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-025-01591-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T07:02:46Z","timestamp":1768374166000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-025-01591-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":129,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1591"],"URL":"https:\/\/doi.org\/10.1007\/s40264-025-01591-0","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"13 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not Applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Data sharing is not applicable to this article as no datasets were generated or analysed.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data sharing"}},{"value":"Data sharing is not applicable to this article as no datasets were generated or analysed.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Software applications or Custom codes"}},{"value":"None.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Drs. Palmer, Rockey, and Lewis serve as consultants to several pharmaceutical companies for activities related to DILI but have not derived any financial or other compensation from activities related to developing this document. Dr. Marcinak is an employee of AbbVie and owns stock in AbbVie. Drs. Seekins, Avigan, Regev, Shastri, and Dash have no conflicts of interest related to this paper.\u00a0Dr.James Lewis is an Editorial Board member\u00a0of Drug Safety. \u00a0Dr.James Lewis was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"M. Palmer, D. Seekins, and A. Dash were involved in conceptualization, methodology, formal analysis, writing original draft as well as review and editing. M. Avigan, J. Marcinak, D.C. Rockey, Arie Regev, V. K. Shastri, and J.H. Lewis were involved in writing during review and editing.\u00a0All authors read and approved the final version.","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}